AMERIPRISE FINANCIAL INC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 102 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,601,384
+1.6%
649,913
+1.1%
0.00%
+100.0%
Q2 2023$4,526,981
+62.3%
643,037
+92.3%
0.00%0.0%
Q1 2023$2,788,804
-70.8%
334,389
-59.8%
0.00%
-66.7%
Q4 2022$9,555,000
+46.2%
832,325
+60.5%
0.00%
+50.0%
Q3 2022$6,535,000
+148.8%
518,702
+108.9%
0.00%
+100.0%
Q2 2022$2,627,000
+20.3%
248,283
+85.0%
0.00%0.0%
Q1 2022$2,183,000
+190.7%
134,228
+182.7%
0.00%
Q2 2021$751,000
+46.7%
47,483
-5.7%
0.00%
Q1 2021$512,000
-2.5%
50,334
-28.7%
0.00%
Q4 2020$525,000
+201.7%
70,574
+39.4%
0.00%
Q3 2020$174,000
-54.3%
50,624
-36.7%
0.00%
Q2 2020$381,000
+1.1%
79,966
-26.6%
0.00%
Q4 2019$377,000
+50.8%
109,019
+25.0%
0.00%
Q3 2019$250,000
-73.8%
87,250
-26.2%
0.00%
Q4 2018$954,000118,223
+393976.7%
0.00%
Q2 2014$0
-100.0%
30
-99.0%
0.00%
Q3 2013$22,0003,0000.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Burrage Capital Management LLC 1,105,673$8,237,0006.28%
Sarissa Capital Management LP 8,175,000$60,903,0006.22%
ORACLE INVESTMENT MANAGEMENT INC 2,980,870$22,207,0002.78%
DG Capital Management, LLC 1,075,732$8,014,0001.70%
Ghost Tree Capital, LLC 900,000$6,705,0001.49%
Parkman Healthcare Partners LLC 538,370$4,011,0001.03%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,835,810$43,477,0000.86%
Formidable Asset Management, LLC 470,419$3,470,0000.80%
KNOTT DAVID M 219,461$1,635,0000.74%
Altium Capital Management LP 250,000$1,863,0000.70%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders